Maze Therapeutics receives positive ratings following recent IPO
Investing.com -- Maze Therapeutics Inc (NASDAQ: MAZE ) received bullish coverage from multiple analysts, with Guggenheim, ...
MIT Technology Review5 小时
Studying the uninvited guests
Trillions of microbes live inside us. Many are helpful; others, not so much. Over the last 15 years MIT has played a central ...
Maze Therapeutics initiated with a Buy at TD Cowen
TD Cowen initiated coverage of Maze Therapeutics (MAZE) with a Buy rating and no price target The company’s MZE829, and oral APOL1 inhibitor, ...
BioMarin Pharmaceutical (NASDAQ:BMRN) Upgraded to Outperform at Oppenheimer
Oppenheimer upgraded shares of BioMarin Pharmaceutical (NASDAQ:BMRN – Free Report) from a market perform rating to an outperform rating in a research note published on Monday morning, MarketBeat ...
The Cool Down on MSN16 小时
Inquiry about the safety of common sweetener sparks debate: 'On par with high fructose corn ...
"Potential effects have been described that need to be investigated by more and better studies.” Inquiry about the safety of ...